Economy

MannKind Corporation (MNKD) Given Consensus Recommendation of "Hold" by Brokerages

MannKind Corporation (MNKD) Given Consensus Recommendation of

Technical Analysis: The Company has the market capitalization of $371.04M. Short shares increased from 23,671,860 to 26,337,802 over that period.

The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt reduction. The company's beta value is at 3.10.

A number of equities analysts recently commented on the company. Finally, ValuEngine lowered shares of MannKind Corporation from a "buy" rating to a "hold" rating in a research note on Tuesday, August 1st.

Among 7 analysts covering Mannkind (NASDAQ:MNKD), 2 have Buy rating, 3 Sell and 2 Hold. Maxim Group reaffirmed a "buy" rating on shares of MannKind Corporation in a report on Friday, September 1st. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. On the other end, a stock with a score from 0-2 would be viewed as weak. About shares traded. MannKind Corporation (NASDAQ:MNKD) has declined 75.27% since November 14, 2016 and is downtrending. For the current year the company's revenue estimates are $13.42 Million compared to low analyst estimates of $12.65 Million and high estimates of $14.19 Million according to the prediction of 2 analysts. The company now has a Return on Equity of -2.70% and Return on Investment of -0.10%. The price to earnings ratio for MannKind Corporation (NasdaqGM:MNKD) is -11.265729. The biopharmaceutical company reported ($0.31) EPS for the quarter, missing the Zacks' consensus estimate of ($0.20) by ($0.11). Its EPS was $-0.28 while outstanding shares of the company were 115.59M. MannKind Corporation had a negative return on equity of 24.93% and a net margin of 71.60%.

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year's free cash flow.

In recent trading day MannKind Corporation (MNKD) stock showed the move of -0.61% with the closing price of $3.24.

More news: Oppo F3 Plus 6GB RAM variant launched: Specs, price and more

In other MannKind Corporation news, Director Kent Kresa acquired 166,600 shares of the company's stock in a transaction on Friday, October 13th. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.60% of the company's stock.

Investors as well as the sell-side will be paying close attention to how the actual numbers compare with the estimates. Bank of New York Mellon Corp lifted its holdings in MannKind Corporation by 30.2% during the 3rd quarter. Hanson Mcclain, Inc. reduced its holdings by shedding 3,000 shares a decrease of 85.7% in the quarter. Wells Fargo & Company MN now owns 89,951 shares of the biopharmaceutical company's stock valued at $196,000 after purchasing an additional 30,589 shares in the last quarter. Macquarie Group Ltd. bought a new position in shares of MannKind Corporation in the 3rd quarter worth about $156,000. Harel Insurance Investments & Financial Services Ltd. now owns 588,520 shares of the biopharmaceutical company's stock worth $830,000 after acquiring an additional 98,520 shares in the last quarter.

Mannkind Corporation (NASDAQ:MNKD)'s revenue estimates for the current quarter are $4.43 Million according to 2 number of analysts, for the current quarter the company has high revenue estimates of $4.66 Million in contradiction of low revenue estimates of $4.2 Million.

WARNING: This report was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this report on another site, it was illegally copied and republished in violation of USA and worldwide copyright and trademark legislation.

MannKind Corporation (MannKind), launched on February 14, 1991, is a biopharmaceutical company. The Firm is focused on the discovery and development of therapeutic products for diseases, such as diabetes.


  • Has JPMorgan Chase & Co (JPM) Improved Earnings Growth In Recent Times?

    It has outperformed by 85.00% the S&P500.The move comes after 6 months negative chart setup for the $250.12 million company. The Firm operates through two business divisions: High Performance Materials & Components, and Flat Rolled Products (FRP).
    McLaren sets gold standard in Dubai

    McLaren sets gold standard in Dubai

    Making its official debut at the Dubai Motor Show , this McLaren 720S was commissioned as a bespoke creation. Exterior upgrades replace the front splitter, air intakes, rear bumper and roof with carbonfibre units.
    O'Neill laments cruel end to Northern Ireland's World Cup hopes

    O'Neill laments cruel end to Northern Ireland's World Cup hopes

    Zlatko Dalic's men will be playing in their fifth World Cup in Russian Federation next year, having only once failed to qualify in 2010."We had a good match in Zagreb but it was hard here".
  • Mozilla Brings Competition to Google Chrome With New Firefox Quantum Browser

    Mozilla Brings Competition to Google Chrome With New Firefox Quantum Browser

    Firefox Quantum will now be having Google as its default search engine across the USA and Canada. Mozilla Firefox Quantum is available now for Windows, Mac and Linux platforms .

    What Do Analysts Say About The Procter & Gamble Company (PG)

    Procter & Gamble Company (The) makes up 2.1% of Tdam USA Inc.'s holdings, making the stock its 6th largest holding. Procter & Gamble Company (The) presently has a consensus rating of "Hold" and a consensus price target of $88.69.
    Rian Johnson Directing New Star Wars Trilogy

    Rian Johnson Directing New Star Wars Trilogy

    Now he's helming three . "Rian will do incredible things with the blank canvas of this new trilogy", said Lucasfilm President Kathleen Kennedy.
  • Hamstring strain likely to sideline Cowboys' Sean Lee at least two games

    Hamstring strain likely to sideline Cowboys' Sean Lee at least two games

    The Eagles have only allowed 598 rushing yards on 3.6 yards an attempt. "We do have the best record in the league", said Blount. Darby has practiced in limited fashion the past three weeks, but he said he was a full participant in a light workout Monday.
    Amazon Confirms Multi-Season 'Lord Of The Rings' TV Series

    Amazon Confirms Multi-Season 'Lord Of The Rings' TV Series

    Tolkien fans are probably rejoicing, it could be a risk for the corporate goliath. Amazon is planning a " Lord of the Rings " TV series, but although J.R.R.
    Group Lotus owner snaps up flying auto  maker

    Group Lotus owner snaps up flying auto maker

    It quoted John Zeng, managing director of LMC Automotive Shanghai, as saying that the investment did not come as a surprise. Terrafugia focuses on engineering, innovation and production of flying cars and on future technologies.
  • Walmart cashier helps calm nervous man paying with change

    He then whispered "I'm so sorry" to the other customers waiting in line as he recounted the mound of coins. As she was standing in line at the check-out, she noticed the older man in front of her struggling to pay.

    Two energy companies investigated for contracts with Puerto Rico

    Documents indicate that Whitefish would still keep one dollar of every two it billed Prepa, the Washington Post reported Tuesday. The Times spoke to six electrical workers from Kissimmee, Fla., who are now working on bringing electricity back to the island.

    Alaska Air Group, Inc

    Finally, Dimensional Fund Advisors LP lifted its position in shares of Alaska Air Group by 3.2% during the third quarter. Days to cover decreased from 5.0 to 3.0 and the percentage of shorted shares is 0.06% as of October 31. (NYSE:ALK).